Clinical trials recruiting in Saransk, Russia

Phase breakdown

Conditions recruiting in Saransk, Russia

Recruiting trials in Saransk, Russia

• Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
  NCT07052578 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
  NCT07108309 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: Female
• Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
  NCT06930859 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Saransk, Russia?

3 recruiting trials have at least one study site in Saransk, Russia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.